Schemes for Drug-Induced Treatment of Osteonecrosis of Jaws with Particular Emphasis on the Influence of Vitamin D on Therapeutic Effects
Drugs that inhibit bone resorption are prescribed most often by orthopedists, hematologists, or oncologists. Dental practice rarely draws attention to their importance and the effects they carry. The problem concerns mainly older people owing to oncological problems or postmenopausal consequences, b...
Main Authors: | Filip Michalak, Sylwia Hnitecka, Marzena Dominiak, Kinga Grzech-Leśniak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/3/354 |
Similar Items
-
Plasma Therapy for Medication-Related Osteonecrosis of the Jaws- A Case Report
by: Maryam Jalili Sadrabad, et al.
Published: (2023-07-01) -
Medication-Related Osteonecrosis of the Jaw—A Continuing Issue
by: Krzysztof Wróbel, et al.
Published: (2021-08-01) -
The Use of Photodynamic Therapy on Medication-Related Osteonecrosis of the Jaws: Animal Study
by: Karapinar Gökay, et al.
Published: (2021-03-01) -
Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
by: Saad Hajeri, BDS, et al.
Published: (2022-09-01) -
The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
by: Christian Bacci, et al.
Published: (2021-01-01)